Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichi Enjyoji

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|June 2, 2010
Tob1 is a constitutively expressed repressor of liver regenerationKaren J Ho, Nhue L Do, Hasan H Otu, et al.
Digestive Diseases and Sciences|October 12, 2010
Variable impact of CD39 in experimental murine colitisBeat M Künzli, Pascal O Berberat, Karen Dwyer, et al.
Glia|December 22, 2007
The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migrationKatrin Färber, Sören Markworth, Ulrike Pannasch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 17, 2014
CD39 improves survival in microbial sepsis by attenuating systemic inflammationBalázs Csóka, Zoltán H Németh, Gábor Törő, et al.
Diabetes|June 24, 2008
Deletion of cd39/entpd1 results in hepatic insulin resistanceKeiichi Enjyoji, Ko Kotani, Chandrashekar Thukral, et al.
The Journal of Clinical Investigation|July 1, 2022
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor modelsHaohai Zhang, Lili Feng, Paola de Andrade Mello, et al.
Hepatology (Baltimore, Md.)|February 11, 2010
Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in miceGuido Beldi, Yara Banz, Alexander Kroemer, et al.
Purinergic Signalling|August 29, 2014
Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasmaZ Gordon Jiang, Yan Wu, Eva Csizmadia, et al.
Purinergic Signalling|April 13, 2011
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancerBeat M Künzli, Maria-Isabell Bernlochner, Stephan Rath, et al.
Journal of Autoimmunity|August 13, 2018
HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's diseaseAnyan Xie, René J Robles, Samiran Mukherjee, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|June 2, 2010
Tob1 is a constitutively expressed repressor of liver regenerationKaren J Ho, Nhue L Do, Hasan H Otu, et al.
Digestive Diseases and Sciences|October 12, 2010
Variable impact of CD39 in experimental murine colitisBeat M Künzli, Pascal O Berberat, Karen Dwyer, et al.
Glia|December 22, 2007
The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migrationKatrin Färber, Sören Markworth, Ulrike Pannasch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 17, 2014
CD39 improves survival in microbial sepsis by attenuating systemic inflammationBalázs Csóka, Zoltán H Németh, Gábor Törő, et al.
Diabetes|June 24, 2008
Deletion of cd39/entpd1 results in hepatic insulin resistanceKeiichi Enjyoji, Ko Kotani, Chandrashekar Thukral, et al.
The Journal of Clinical Investigation|July 1, 2022
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor modelsHaohai Zhang, Lili Feng, Paola de Andrade Mello, et al.
Hepatology (Baltimore, Md.)|February 11, 2010
Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in miceGuido Beldi, Yara Banz, Alexander Kroemer, et al.
Purinergic Signalling|August 29, 2014
Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasmaZ Gordon Jiang, Yan Wu, Eva Csizmadia, et al.
Purinergic Signalling|April 13, 2011
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancerBeat M Künzli, Maria-Isabell Bernlochner, Stephan Rath, et al.
Journal of Autoimmunity|August 13, 2018
HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's diseaseAnyan Xie, René J Robles, Samiran Mukherjee, et al.
Pageof 5